Dominique Vanfleteren

Dominique Vanfleteren currently serves as Interim CFO at Ncardia since April 2023. Prior experience includes roles as Chief Operations Officer at Graftys from May 2021 to October 2021 and Chief Financial Officer at Oxurion NV from January 2015 to December 2020. Dominique held various positions at UCB Pharma from July 2002 to August 2014, including CFO for Asia-Pacific/Japan and Senior Director of Mid-Markets Controlling. Earlier in the career, Dominique served as Finance Director at GSK from 1986 to 2002. Dominique holds a Master of Sciences in Management, specializing in Management Sciences and Quantitative Methods, from Université catholique de Louvain, obtained between 1981 and 1983.